Pharmaceutical firm AstraZeneca has announced that its coronavirus vaccine has an efficacy rate near to that of the Pfizer and Moderna’s versions, and reports indicate that the two-shot inoculation could be approved “as early as today.”
The Daily Mail reported that AstraZeneca CEO Pascal Soriot said, “We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else.”
FRIENDS > I those who follow my account know very well I have said all along that #OxfordVaccine #AstraZeneca #OXFAZN was the safest vaccine BUT would also be the best, most efficient vaccine & the one I'll be taking.
Real effectiveness is a #WINNER #NHShttps://t.co/Xzo8x8baO2
— PoliticalPig (@politicalpig) December 27, 2020
RELATED: Ayanna Pressley, Member Of AOC’s ‘Squad,’ Calls For The Incarcerated To Be ‘Prioritized’ For Vaccine
UK’s Daily Mail: ‘Officials Reportedly Prepare To Approve The Oxford-AstraZeneca Jab’
The Daily Mail noted, “His comments come as officials reportedly prepare to approve the Oxford-AstraZeneca jab as early as tomorrow.”
On November 23, AstraZeneca and Oxford University announced that their jointly created coronavirus vaccine is easier to distribute than the Pfizer version, which must be stored at -94 degrees.
On Sunday, Vaccines Minister Nadhim Zahawi told The Sun, “The heroic efforts of the team at the University of Oxford have paid off, with its home-grown vaccine shown to be effective in older people as well as young.”
“From day one of the pandemic, people from across the nation have been working day and night to find a safe and effective Covid-19 vaccine,” Zahawi added.
Oxford Covid vaccine set to be approved MONDAY as huge efforts 'pay off' https://t.co/tZyaRRRZ5Y
— Sun Politics (@SunPolitics) December 26, 2020
UK Vaccines Minister Touts Success
A hopeful Zahawi continued, “We have seen the best of British at every stage, from our world-leading scientists working around the clock to carry out vital research, to builders and engineers constructing new facilities.”
“Manufacturers are boosting their capabilities and hundreds of thousands of people in every corner of the UK are taking part in clinical trials — developing, finding and preparing for a vaccine has involved us all,” he finished.
The Telegraph reported on Saturday that the UK planned to roll out the vaccine to all citizens on January 4th.
The United Kingdom will roll out Oxford University’s COVID-19 vaccine from Jan. 4, according to plans being drawn up by ministers, The Sunday Telegraph reported.#oxfordvaccine #uk pic.twitter.com/8VEigYFdWU
— flora williams (@florawilliamsdr) December 27, 2020
RELATED: Rand Paul Calls For Us To ‘Open The Economy Up’ – Says It’s Our Only Chance Of Recovering
Reason To Be Encouraged
One hazard in developing vaccines is that virii are always changing.
The Associated Press reported last Sunday, “Health experts in the U.K. and U.S. said the strain seems to infect more easily than others, but there is no evidence yet it is more deadly.”
The same is true of the flu, and that the new coronavirus mutations have not been deadlier is encouraging.
How quickly vaccines can be distributed to all citizens in the U.S. and abroad remains to be seen, but these early stories give reason for optimism.